U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Sat Dec 16 11:02:30 GMT 2023
Edited
by admin
on Sat Dec 16 11:02:30 GMT 2023
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type IGG2
Sequence Origin CHIMERIC/HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
1W14T9L25W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NAVICIXIZUMAB
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
IMMUNOGLOBULIN G2-KAPPA, ANTI-(HOMO SAPIENS DLL4(DELTA-LIKE 4)) AND ANTI-(HOMO SAPIENS VEGFA (VASCULAR ENDOTHELIAL GROWTH FACTOR A,VEGF-A, VEGF)), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY, BISPECIFIC
Common Name English
Navicixizumab [WHO-DD]
Common Name English
OMP 305B83 [WHO-DD]
Common Name English
NAVICIXIZUMAB [USAN]
Common Name English
OMP-305B83
Code English
navicixizumab [INN]
Common Name English
Code System Code Type Description
FDA UNII
1W14T9L25W
Created by admin on Sat Dec 16 11:02:30 GMT 2023 , Edited by admin on Sat Dec 16 11:02:30 GMT 2023
PRIMARY
DRUG BANK
DB12634
Created by admin on Sat Dec 16 11:02:30 GMT 2023 , Edited by admin on Sat Dec 16 11:02:30 GMT 2023
PRIMARY
USAN
DE-134
Created by admin on Sat Dec 16 11:02:30 GMT 2023 , Edited by admin on Sat Dec 16 11:02:30 GMT 2023
PRIMARY
NCI_THESAURUS
C119620
Created by admin on Sat Dec 16 11:02:30 GMT 2023 , Edited by admin on Sat Dec 16 11:02:30 GMT 2023
PRIMARY
INN
10220
Created by admin on Sat Dec 16 11:02:30 GMT 2023 , Edited by admin on Sat Dec 16 11:02:30 GMT 2023
PRIMARY
CAS
1638338-43-8
Created by admin on Sat Dec 16 11:02:30 GMT 2023 , Edited by admin on Sat Dec 16 11:02:30 GMT 2023
PRIMARY
From To
1_22 1_96
1_148 1_204
1_261 1_321
1_367 1_425
2_22 2_96
2_146 2_202
2_259 2_319
2_365 2_423
2_133 3_218
1_135 4_218
1_223 2_221
1_224 2_222
1_227 2_225
1_230 2_228
3_23 3_92
3_138 3_198
4_23 4_92
4_138 4_198
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_295
N 2_297
Related Record Type Details
.DELTA.-LIKE PROTEIN 4
TARGET -> INHIBITOR
HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A
TARGET -> INHIBITOR
Related Record Type Details
NAVICIXIZUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:SEQUENCE(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966